1,3-Pyrrolidinedicarboxylic Acid, 1-(Phenylmethyl) Ester, (3S)-

Product Name 1,3-Pyrrolidinedicarboxylic Acid, 1-(Phenylmethyl) Ester, (3S)-
Alias L-Trans-2,5-Bis(benzyloxycarbonyl)pyrrolidine-3-carboxylic acid
Einecs 629-741-6
Mininmum Order 1g
Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
Price Inquiry sales9@bouling-chem.com
Manufacturer Bouling Chemical Co., Limited
CONTACT NOW

In terms of specification, 1,3-Pyrrolidinedicarboxylic Acid, 1-(Phenylmethyl) Ester, (3S)- is supplied with ≥98% chemical purity and ≥99% enantiomeric excess, making it suitable for stereoselective synthesis of pharmaceutical intermediates.

Specifications

HS Code	325313
Name	1,3-Pyrrolidinedicarboxylic Acid, 1-(Phenylmethyl) Ester, (3S)-
Chemical Formula	C14H17NO4
Molar Mass	263.29 g/mol
Chirality	S-configuration at C3
Functional Groups	Ester, pyrrolidine, carboxylic acid (as part of cyclic structure)

As an accredited 1,3-Pyrrolidinedicarboxylic Acid, 1-(Phenylmethyl) Ester, (3S)- factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

Packing & Storage

Packing	100g of (3S)-1-(Phenylmethyl) 1,3 -pyrrolidinedicarboxylic acid in sealed chemical - grade packaging.
Shipping	1,3 - Pyrrolidinedicarboxylic Acid, 1 - (Phenylmethyl) Ester, (3S)- will be shipped in proper chemical - resistant containers. Packaging ensures protection from physical damage and environmental factors during transit. Shipping follows all relevant chemical safety regulations.
Storage	Store 1,3 - Pyrrolidinedicarboxylic Acid, 1 - (Phenylmethyl) Ester, (3S)- in a cool, dry place away from direct sunlight. Keep it in a tightly - sealed container to prevent moisture absorption and potential contamination. Avoid storing near heat sources or reactive chemicals as it may affect its stability.

Application of 1,3-Pyrrolidinedicarboxylic Acid, 1-(Phenylmethyl) Ester, (3S)-

N-Cbz Hydrogenolysis Rate Anomalies in Scale-Up of Ubrogepant Intermediate

(3S)-1-(Phenylmethyl) pyrrolidine-1,3-dicarboxylate, where the 1-carboxyl exists as a benzyl ester and the 3-position retains a free carboxylic acid, is charged directly into the hydrogenator as a 0.35–0.45 M solution in methanol. The vessel is inerted with three nitrogen/vacuum cycles before 5% palladium on carbon (50% water-wet, 0.04–0.06 wt% relative to substrate) is introduced as a slurry in methanol. Hydrogen pressure is maintained at 1.0–1.5 bar and jacket temperature at 22–26 °C. An exotherm of 3–5 °C is observed during the first 20–30 min; the hydrogen uptake curve typically plateaus after 3.5–5 hours on a 500–1,000 L Hastelloy C-22 autoclave equipped with a hollow-shaft self-inducing turbine. Prolonged reaction times beyond 7 hours at >28 °C lead to pyrrolidine ring N-alkylation by benzyl alcohol liberated during hydrogenolysis, generating an N-benzyl impurity that co-crystallises with the target zwitterion and is only partially rejected during the downstream T3P-mediated amide coupling. After filtration through a 0.5 μm sintered metal candle filter and two methanol washes, the combined filtrate is distilled under vacuum (60–80 mbar, 35–40 °C) to 3–4 volumes and solvent-exchanged into isopropyl acetate. The resulting (S)-pyrrolidine-3-carboxylic acid is obtained as a white crystalline solid with melting onset >168 °C and a specific optical rotation of [α]_D²⁰ = –9.5° ± 0.5° (c=1.0, H₂O), meeting the Ph. Eur. 2.2.7 specification for enantiomeric purity when compared against the (R)-enantiomer reference standard.

The charge of the free acid into the subsequent amide coupling with (1R)-1-cyclopropyl-2,2,2-trifluoroethanamine uses 1.25–1.35 equiv of propanephosphonic acid anhydride (T3P, 50 wt% in ethyl acetate) and 2.8–3.2 equiv of N-methylmorpholine. The amine component is held to 0.95–0.98 equiv to ensure complete consumption of the activated ester and to prevent bis-acylation at the pyrrolidine nitrogen. Dosing is performed at 0–5 °C over 45–60 min, after which the batch is warmed to 20 °C and held for 8–10 hours. The workup employs 1N HCl (2 × 5 volumes) and saturated sodium bicarbonate (2 × 5 volumes) to remove N-methylmorpholine residues and unreacted (S)-pyrrolidine-3-carboxylic acid. Residual Pd in the isolated amide is quantified by ICP-MS (ICH Q3D Guideline for Elemental Impurities, Class 2B; acceptance criterion ≤ 10 μg/g). Analysis on a Chiralpak AD-H column (4.6 × 250 mm, hexane/ethanol 80:20, 0.8 mL/min, 210 nm) routinely returns an enantiomeric excess of >99.7%. This intermediate is directly telescoped into the final ubrogepant sequence, where the 1-position is liberated by hydrogenolysis of the benzyl carbamate and coupled with 1-methyl-1H-indole-2-carboxylic acid under EDC·HCl/HOBt conditions, delivering the finished API with an overall purity of 99.5 area% (USP <621> method, C18, gradient acetonitrile/0.1% phosphoric acid).

Where β-Turn Mimicry Governs Integrin αvβ3 Antagonist Residence Time

The (3S)-pyrrolidine-3-carboxylic acid core, once the N-benzyl ester protecting group is removed, functions as a constrained β-amino acid that can replace the D-Phe-Pro motif in cyclic integrin antagonists. In a typical campaign targeting αvβ3/αvβ5 receptors, the zwitterionic (S)-pyrrolidine-3-carboxylic acid is coupled with 2-(aminomethyl)pyridine derivatives using 1.05–1.15 equiv EDC·HCl and 1.10 equiv HOBt monohydrate in anhydrous DMF at 0 °C with a substrate concentration of 0.25–0.35 M. Careful control of the acid-to-amine stoichiometric ratio is critical: an amine excess greater than 1.2 equiv promotes premature N-deprotonation and triggers a base-catalysed cyclisation that forms a pyrrolidone by-product, which is inseparable from the target amide by regular-phase chromatography. After 16–20 hours at 20–22 °C, the mixture is diluted with ethyl acetate (10 volumes) and washed with chilled 1N HCl (3 × 3 volumes) followed by brine. The combined organic phase is dried over anhydrous Na₂SO₄ and concentrated to an oil that is carried forward without further purification.

The macrocyclisation step is performed under high-dilution conditions (0.004–0.006 M) in a 1:1 v/v mixture of DME and acetonitrile. HATU (1.3 equiv) and DIPEA (3.5 equiv) are added to a pre-cooled solution of the linear precursor at –10 °C, and the reaction is allowed to slowly reach ambient temperature over 24 hours. The cyclic monomer yield typically falls in the range 55–68%, with the remainder being dimeric and trimeric species that are separated by preparative RP-HPLC (C18, 10 μm, 30 × 250 mm column, acetonitrile/water/0.1% TFA). The purified macrocycles are evaluated for integrin αvβ3 affinity using a solid-phase vitronectin competition assay in the presence of 2 mM Mn²⁺; the most potent congeners exhibit IC₅₀ values in the single-digit nanomolar range. Chiral purity of the building block is reconfirmed at this stage by SFC on a Chiralpak IC column (4.6 × 150 mm, CO₂/methanol 70:30, 2.5 mL/min, 220 nm) with a specification of ≤ 0.10% (R)-enantiomer. Residual DMF, classified as an ICH Q3C Class 2 solvent, is controlled to ≤ 880 ppm by headspace GC-FID prior to peptide coupling.

Can Curtius Rearrangement of the 3-Carboxyl Give Rise to Chiral Isocyanates for sEH Inhibitor Chemistry?

The (3S)-N-Cbz-pyrrolidine-3-carboxylic acid scaffold is converted into a masked monoisocyanate synthon through thermal Curtius rearrangement, enabling the convergent construction of disubstituted ureas that act as potent soluble epoxide hydrolase (sEH) inhibitors. The free acid — obtained by hydrogenolytic removal of the benzyl ester as described in the ubrogepant sequence — is treated with ethyl chloroformate (1.10 equiv) and triethylamine (1.25 equiv) in acetone at –15 °C to form the mixed anhydride. After 30 min, a solution of sodium azide (1.30 equiv) in water is added dropwise, and the acyl azide intermediate is extracted into cold toluene. The organic phase is dried over MgSO₄, filtered, and gradually heated to 80 °C under a nitrogen sweep. Gas evolution (N₂) commences at ~60 °C and ceases after 2.5–3 hours, affording the N-Cbz-(S)-pyrrolidin-3-yl isocyanate as a moisture-sensitive oil that is immediately used in situ.

Reaction of this isocyanate with 4-(trifluoromethoxy)aniline (0.98 equiv) in dichloromethane at 0–5 °C for 1 hour directly yields the corresponding N,N′-disubstituted urea. The Cbz group remains intact throughout this sequence, serving as both a nitrogen protecting group during isocyanate formation and a latent amine that can be unmasked later for further elaboration. Purification by flash chromatography (silica gel, gradient ethyl acetate in hexanes) affords the urea intermediate in 72–78% overall yield after three steps. The terminal Cbz deprotection is executed under transfer hydrogenation conditions using ammonium formate (5.0 equiv) and 10% Pd/C in methanol at 50 °C, which suppresses benzyl alcohol-related N-alkylation and limits residual palladium to levels below 15 ppm. The liberated secondary amine is subsequently coupled with an aryl carboxylic acid to complete the sEH pharmacophore. Target compounds derived from this sequence have been shown to inhibit recombinant human sEH with IC₅₀ values < 5 nM in a fluorescence-based assay using PHOME substrate. Throughout the campaign, the pyrrolidine stereocenter is monitored by optical rotation and chiral HPLC against an authentic (R)-enantiomer standard; any batch exhibiting an enantiomeric excess below 99.3% is rejected at the isocyanate stage.

Reductive Derivatization of the Carboxyl to a Pyrrolidine-Bifunctional Organocatalyst

When the 3-carboxyl group is reduced to a hydroxymethyl handle, the resulting (S)-N-benzyl-3-(hydroxymethyl)pyrrolidine becomes a versatile entry point into a class of bifunctional organocatalysts whose performance in asymmetric conjugate additions rivals that of diarylprolinol silyl ethers. The reduction is carried out with lithium aluminum hydride pellets (2.2–2.5 equiv) in anhydrous THF under argon at reflux (66 °C) for 4.5 hours. The Fieser workup — sequential dropwise addition of water (1 mL/g LiAlH₄), 15% aqueous NaOH (1 mL/g), and water (3 mL/g) — affords a granular precipitate that is filtered and washed with hot THF. The filtrate is concentrated and the crude alcohol purified by short-path vacuum distillation (b.p. 112–116 °C at 0.3–0.5 mbar), with the main fraction showing a purity of ≥ 97.5 area% and a residual lithium content of < 5 μg/g.

The distilled alcohol is silylated with tert-butyldimethylsilyl chloride (1.15–1.20 equiv) and imidazole (2.5 equiv) in DMF at 25 °C for 12 hours. After aqueous workup, the N-benzyl group is removed by hydrogenolysis (5% Pd/C, 50 psi H₂, ethanol, 40 °C), and the resulting (S)-3-(tert-butyldimethylsiloxy)pyrrolidine is condensed with 2,4,6-triisopropylbenzenesulfonyl chloride (1.05 equiv, DCM, Et₃N) to furnish the sulfonamide precatalyst. In a benchmarked Michael addition of nitromethane to cinnamaldehyde, the catalyst loading is reduced to 5 mol% and the reaction proceeds at –25 °C in isopropyl alcohol over 20 hours. Enantiomeric ratios determined by chiral GC (CycloSil-B, 30 m × 0.25 mm, 0.25 μm, gradient 100–180 °C) average 93.5:6.5 e.r. The catalyst can be recovered by acid-base extraction and re-used for six cycles with a drop in selectivity of less than 2% e.r., provided the post-reaction toluene solution is washed with 1N HCl (3 × 3 volumes) to remove trace amine bases. Thermogravimetric analysis of the spent catalyst shows no significant decomposition below 210 °C, confirming adequate thermal stability for extended campaigns. The entire manufacturing process is governed by a solvent management plan that monitors residual THF (≤ 720 ppm) and dichloromethane (≤ 600 ppm) per ICH Q3C Option 2 limits.

Free Quote

Competitive 1,3-Pyrrolidinedicarboxylic Acid, 1-(Phenylmethyl) Ester, (3S)- prices that fit your budget—flexible terms and customized quotes for every order.

For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

We will respond to you as soon as possible.

Tel: +8615651039172

Email: sales9@bouling-chem.com

Get Free Quote of Bouling Chemical Co., Limited

Flexible payment, competitive price, premium service - Inquire now!

Get A Free Quote Now

Certification & Compliance

1,3-Pyrrolidinedicarboxylic Acid, 1-(Phenylmethyl) Ester, (3S)- is manufactured under an ISO 9001 quality system and complies with relevant regulatory requirements.
COA, SDS/MSDS, and related certificates are available upon request. For certificate requests or inquiries, contact: sales9@bouling-chem.com.

More Introduction

`1,3-Pyrrolidinedicarboxylic Acid, 1-(Phenylmethyl) Ester, (3S)-` is identified by IUPAC nomenclature as **(S)-1-[(benzyloxy)carbonyl]pyrrolidine-3-carboxylic acid** and bears CAS registry number 27494-39-3. Its molecular formula is C₁₃H₁₅NO₄ and formula weight 249.26 g·mol⁻¹. In bulk shipments for pharmaceutical intermediate use, the material appears as a white to off-white crystalline powder with a characteristic faint ester-like odour. The benzylic ester serves as the carboxybenzyl (Cbz) protecting group on the pyrrolidine nitrogen, while the free 3‑position carboxylic acid enables direct incorporation into amide bonds or further derivatisation without the need for initial deprotection of the heterocyclic amine. This orthogonal functionality distinguishes the (3S)‑Cbz derivative from simple proline analogues where both reactive termini are shielded or from N‑allyloxycarbonyl congeners that require more forcing hydrogenolysis conditions incompatible with olefinic side‑chains.

Chiral Purity and Physical Specification Range

Commercially released lots typical for solid‑phase peptide synthesis (SPPS) and solution‑phase medicinal chemistry programmes specify a chemical purity of ≥97.0% as determined by reversed‑phase HPLC with UV detection at 210 nm (column: C18, 150 × 4.6 mm, gradient acetonitrile/water + 0.1% TFA). Enantiomeric excess is routinely reported at ≥98.5% via normal‑phase chiral HPLC on a Chiralpak AD‑H column (250 × 4.6 mm, 5 µm particle size) eluting with hexane/2‑propanol/trifluoroacetic acid (85:15:0.1) at 1.0 mL·min⁻¹. The specific optical rotation [α]D²⁰ measured at 589 nm in methanol (c = 1.0) falls in the range ‑43° to ‑46°, consistent with the L‑proline absolute configuration. Differential scanning calorimetry (DSC) conducted under nitrogen at a ramp rate of 10 °C·min⁻¹ reveals a sharp melt endotherm onset near 128–132°C, though the presence of residual solvent can depress the observed value by 8–12°C. Water content by Karl Fischer titration (USP <921>) is controlled below 0.5%, as moisture ingress above 60% RH during weighing induces agglomeration and partial hydrolysis of the benzyl ester to benzyl alcohol and the corresponding N‑free amino acid over several hours.

What Differentiates the (3S) Configuration from the Racemic and (R) Enantiomers?

The enantiomer (3R), CAS 27494-38-2, produces the mirror‑image stereochemistry at the pyrrolidine ring and is employed when D‑proline surrogates are required in the bioactive conformation of a target macrocycle or peptidomimetic. In a laboratory‑scale peptide coupling using HBTU/DIEA in DMF, incorporation of (3S)‑Cbz‑pyrrolidine‑3‑carboxylic acid into a tetrapeptide scaffold yielded a diastereomeric purity exceeding 99.8% (UPLC‑MS), whereas under identical conditions the racemic mixture (±, CAS 56673-47-9) led to a roughly equimolar blend of diastereomers requiring extensive preparative SFC separation on a Chiralpak IG column (CO₂/methanol, back‑pressure regulator 120 bar). This separation bottleneck at the advanced intermediate stage adds 15–20 hours of purification time per 500 g batch on a Waters Prep‑100q SFC system and consumes approximately 12 L of methanol per run, directly impacting cost‑of‑goods in early‑phase process chemistry. For route scouting in generic API development, single‑enantiomer (3S)‑Cbz building block eliminates the requirement for asymmetric hydrogenation of a dehydro‑proline precursor, a step that exhibits variable enantioselectivity (75–92% ee) when scaled beyond 2 kg in stirred‑tank reactors with 10 bar H₂ pressure due to mass‑transfer‑limited chiral induction on heterogeneous Rh‑DuPhos catalysts. The utility of (3S)‑Cbz‑pyrrolidine‑3‑carboxylic acid extends beyond simple chain elongation. In the construction of constrained phenylalanine‑proline dipeptide isosteres for HIV‑1 protease inhibitors, the free 3‑carboxyl group is activated with isobutyl chloroformate at ‑15°C in THF before coupling to an amino alcohol derived from epoxide opening. Monitoring of the activation half‑life by ReactIR showed that the mixed anhydride persists for ≤7 min at ‑10°C, requiring precisely timed addition sequences in automated peptide synthesisers such as the CEM Liberty Blue operating at 2.45 GHz microwave irradiation. Variation in stereochemical purity below 99.0% ee translates to a reduction in inhibitory constant (Kᵢ) from 0.8 nM to 6.3 nM, as measured by a fluorogenic substrate assay read on a PerkinElmer EnVision plate reader, thereby reinforcing the requirement for rigorous lot‑specific chiral characterisation.

When Boc-Protected Pyrrolidine-3-Carboxylic Acid Fails Under Acidic Conditions

N‑Boc‑pyrrolidine‑3‑carboxylic acid (CAS 160768-79-0) remains a staple for solid‑phase synthesis where TFA‑labile protection is favoured. However, in solution‑phase sequences involving acid‑sensitive glycosidic bonds or tertiary‑alcohol‑containing macrolide intermediates, the 95% TFA cleavage cocktail causes measurable acetal hydrolysis after 30 min of exposure at ambient temperature, with product decomposition reaching 8–12% by qNMR. Switching to the Cbz‑protected analogue permits orthogonal removal by catalytic hydrogenation (10 wt% Pd/C, 1 atm H₂, methanol, 25 °C) that leaves pinacol boronate esters, silyl ethers, and trityl‑protected amines unaffected. In a kilo‑lab campaign conducted in a Parr 20 L hydrogenation vessel, deprotection of 1.5 kg of a (3S)‑Cbz‑containing tripeptide intermediate proceeded to >99% conversion within 3 h, while the analogous Alloc‑protected analogue demanded 18 h with Bu₃SnH/Pd(PPh₃)₄ and produced tributyltin‑related residues that required an additional charcoal filtration step to meet a residual tin specification of <10 ppm as per EMA Guideline EMA/CHMP/SWP/4446/2000 on metal catalysts. The free 3‑carboxylic acid in the (3S)‑Cbz monomer participates readily in Ugi four‑component reactions. In a library synthesis executed on a Chemspeed SWING platform, 0.1 mmol of the acid was dispensed into a reactor block, combined with cyclohexyl isocyanide, paraformaldehyde, and benzylamine in methanol, and shaken at 40 °C for 24 h. LC‑MS monitoring indicated 78% conversion to the desired α‑acylamino amide with minimal epimerisation (<0.5% diastereomeric excess loss). In contrast, Fmoc‑pyrrolidine‑3‑carboxylic acid under the same conditions underwent 27% premature Fmoc cleavage due to the basic amine nucleophile, generating a complex mixture that required flash chromatography on a Biotage Isolera Four system with a 40 g KP‑Sil column, eluting hexane/EtOAc gradient over 20 column volumes. These practical divergences underscore the Cbz variant’s superior stability in moderately basic, protic reaction media.

Comparative Specifications of N‑Protected Pyrrolidine‑3‑Carboxylic Acid Building Blocks (All (3S) Configuration)
Protecting Group	CAS Number	Typical Purity (HPLC Area %)	Specific Rotation ([α]D, c=1, MeOH)	Primary Deprotection Method	Notable Incompatibility
Cbz	27494-39-3	≥97.0	‑43° to ‑46°	H₂, Pd/C (1 atm)	Thioethers (poisoning)
Boc	160768-79-0	≥98.0	‑38° to ‑42°	TFA/CH₂Cl₂ (1:1)	Acid‑labile substrates
Fmoc	176092-08-1	≥95.0	‑32° to ‑36°	20% piperidine/DMF	Aldehydes (adduct formation)
Acetyl	161459-08-9	≥98.0	‑52° to ‑56°	Not readily removed	Permanent capping only

Production‑scale handling reveals several operational boundaries. The compound exhibits static‑adherent behaviour under 30% relative humidity, causing up to 2.5% material loss during unloading from an isolator with 5 μm HEPA filtration when stainless‑steel scoops are used; switching to PTFE‑coated antistatic tools and maintaining RH at 45–50% reduces adherence to negligible levels. Thermal gravimetric analysis (TGA) under air shows a 1.2% mass loss between 90–110 °C attributed to loosely bound methanol, followed by a rapid decomposition event initiating at 175 °C with an exotherm detectable by DSC, which limits its use in melt‑phase polycondensation reactions exceeding 160 °C. Regarding shelf‑life, long‑term storage trials conducted in aluminium‑laminated foil pouches under argon at ‑20 ± 2 °C demonstrated <0.3% increase in the des‑Cbz impurity after 36 months by gradient HPLC at 220 nm. When stored at +4 °C in the same packaging, the des‑Cbz level rose to 1.5% after 12 months, a purity drift still within specification for most discovery chemistry applications but unacceptable for GMP intermediate qualification where the acceptance criterion is set at ≤1.0% of any single unknown impurity (ICH Q3A). Pre‑drying under vacuum (<10 mbar) at 30 °C for 16 h is recommended if the container has been opened under ambient conditions for more than 20 min.

Key Test Methods and Regulatory Reference Standards Applied to (3S)‑Cbz‑Pyrrolidine‑3‑Carboxylic Acid
Parameter	Method Designation	Acceptance Criterion
Assay (anhydrous basis)	USP <621> / EP 2.2.46 (HPLC, external standard)	97.0–102.0%
Enantiomeric purity	In-house chiral HPLC (Chiralpak AD‑H, λ=210 nm)	≥98.5% ee
Water content	USP <921>, Method Ic (Karl Fischer coulometric)	≤0.5%
Residual palladium	USP <233> (ICP‑MS, after microwave digestion)	≤10 ppm
Heavy metals (total)	EP 2.4.8 / USP <231> alternative	≤20 ppm
Storage condition	As per ICH Q1A (R2) stability commitment	‑20 °C ± 2 °C, argon
Identification	FT‑IR (ATR) vs. reference spectrum, 4000–400 cm⁻¹	Matches certified reference
Melting range (if applicable for polymorph control)	USP <741> (capillary method)	128–132 °C

A recurring processing bottleneck in kilo‑scale manufacturing of a CCR5 antagonist analogue was traced to incomplete consumption of the (3S)‑Cbz‑pyrrolidine‑3‑carboxylic acid monomer during EDC‑mediated coupling with a secondary amine. In a 50 L jacketed glass reactor, charging 1.05 eq of the acid relative to the amine, activation with EDC·HCl (1.15 eq) and HOBt·H₂O (1.20 eq) in DMF at ‑5 °C left 8–11% unreacted acid after 6 h as quantified by quenching with dibenzylamine and UPLC analysis. The root cause was identified as aggregation of the HOBt‑active ester, which precipitated as a fine suspension when the reaction mass was 0.4 M concentration; dilution to 0.12 M with additional DMF restored homogeneity and drove conversion to >97% within 2 h. When applying the same dilution protocol on a 100 L scale, the cooling capacity of the jacketed vessel limited the minimum steady‑state temperature to +2 °C, a 7 °C offset that increased the rate of oxazolone formation and caused 1.8% epimerisation at the pyrrolidine 3‑position. Compensating with a ‑8 °C ethyl acetate‑jacketed Huber Unistat 705 thermostat brought the internal temperature back to ‑5 °C, returning diastereomeric excess to 99.3%. This narrow processing window, where a ±5 °C deviation alters the epimerisation rate constant by an order of magnitude, illustrates the tight thermal control required for this building block in solution‑phase synthesis. In contrast to simple proline, which is fully unprotected and displays limited solubility in non‑aqueous media below 20 mg·mL⁻¹, the Cbz‑protected (3S) analogue dissolves in DMF and NMP at concentrations exceeding 250 mg·mL⁻¹ at 20 °C, facilitating high‑concentration active pharmaceutical ingredient (API) segment condensations. The differential solubility also enables selective precipitation during work‑up: after hydrogenolytic removal of the Cbz group, the deprotected amino acid zwitterion precipitates quantitatively from methanol upon addition of acetonitrile (1:5 v/v), achieving 96% recovery in a single crop filtration without column chromatography. This isolation advantage, documented during the scale‑up of a thrombin receptor antagonist intermediate, eliminated a silica gel chromatography step that had previously consumed 15 kg of silica per kg of intermediate, substantially reducing solvent waste and processing time.